Ashok Kumar, Aman Shukla, P. Shinu, ,. B. Mathew, Shashank Kailkhura, Pranjal Pratap Singh, Anroop B Nair
{"title":"抗生素处方合理化:肠道微生物组的调节和减少抗生素耐药性风险的可能性-一篇叙述性综述","authors":"Ashok Kumar, Aman Shukla, P. Shinu, ,. B. Mathew, Shashank Kailkhura, Pranjal Pratap Singh, Anroop B Nair","doi":"10.1177/0976500x231189341","DOIUrl":null,"url":null,"abstract":"Antimicrobial resistance (AMR) is a serious global health issue, and it is greatly influenced by the gut flora. The rationalization of antimicrobial doses in clinical studies is crucial for preventing AMR. This review analyzes how rationalization tactics affect AMR and gut microbiota in clinical studies. Studies that provided data on the use of antibiotics, AMR, or gastrointestinal microbiota were taken into account for the current review. The AMR rate was found to be low when healthy gut flora was maintained using various antibiotic rationalization techniques, such as limited use of antibiotics or targeted treatments. However, the effectiveness of these strategies differed based on the particular intervention, the research population, and the length of the course of therapy. The rationalization of antibiotic prescriptions in clinical research is one potential method for reducing the prevalence of AMR by maintaining the gut flora. Rationalization techniques may help lower AMR rates and foster the development of good intestinal flora. This review describes various antibiotic rationalization techniques and the importance of maintaining healthy microbial flora to minimize AMR-associated health issues.","PeriodicalId":16761,"journal":{"name":"Journal of Pharmacology & Pharmacotherapeutics","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2023-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Rationalization of Antibiotic Prescription: Modulation of the Gut Microbiome and Possibilities of Minimizing the Risks for the Development of Antibiotic Resistance—A Narrative Review\",\"authors\":\"Ashok Kumar, Aman Shukla, P. Shinu, ,. B. Mathew, Shashank Kailkhura, Pranjal Pratap Singh, Anroop B Nair\",\"doi\":\"10.1177/0976500x231189341\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Antimicrobial resistance (AMR) is a serious global health issue, and it is greatly influenced by the gut flora. The rationalization of antimicrobial doses in clinical studies is crucial for preventing AMR. This review analyzes how rationalization tactics affect AMR and gut microbiota in clinical studies. Studies that provided data on the use of antibiotics, AMR, or gastrointestinal microbiota were taken into account for the current review. The AMR rate was found to be low when healthy gut flora was maintained using various antibiotic rationalization techniques, such as limited use of antibiotics or targeted treatments. However, the effectiveness of these strategies differed based on the particular intervention, the research population, and the length of the course of therapy. The rationalization of antibiotic prescriptions in clinical research is one potential method for reducing the prevalence of AMR by maintaining the gut flora. Rationalization techniques may help lower AMR rates and foster the development of good intestinal flora. This review describes various antibiotic rationalization techniques and the importance of maintaining healthy microbial flora to minimize AMR-associated health issues.\",\"PeriodicalId\":16761,\"journal\":{\"name\":\"Journal of Pharmacology & Pharmacotherapeutics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2023-08-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmacology & Pharmacotherapeutics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/0976500x231189341\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacology & Pharmacotherapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0976500x231189341","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Rationalization of Antibiotic Prescription: Modulation of the Gut Microbiome and Possibilities of Minimizing the Risks for the Development of Antibiotic Resistance—A Narrative Review
Antimicrobial resistance (AMR) is a serious global health issue, and it is greatly influenced by the gut flora. The rationalization of antimicrobial doses in clinical studies is crucial for preventing AMR. This review analyzes how rationalization tactics affect AMR and gut microbiota in clinical studies. Studies that provided data on the use of antibiotics, AMR, or gastrointestinal microbiota were taken into account for the current review. The AMR rate was found to be low when healthy gut flora was maintained using various antibiotic rationalization techniques, such as limited use of antibiotics or targeted treatments. However, the effectiveness of these strategies differed based on the particular intervention, the research population, and the length of the course of therapy. The rationalization of antibiotic prescriptions in clinical research is one potential method for reducing the prevalence of AMR by maintaining the gut flora. Rationalization techniques may help lower AMR rates and foster the development of good intestinal flora. This review describes various antibiotic rationalization techniques and the importance of maintaining healthy microbial flora to minimize AMR-associated health issues.